GGrantIndex
Sort

40,608 grants matching prostate cancer

HEPARIN-BINDING EGF-LIKE FACTORS IN PROSTATE GROWTH

$361,146
Michael R Freeman · Boston Children'S Hospital · R37 · FY2008 · DK

EDUCATION, TRAINING, AND OUTREACH CORE

$361,133
Robert S Langer · Massachusetts Institute Of Technology · U54 · FY2009 · CA

A Health IT based Psychoeducational Intervention for African American Prostate Cancer

$361,128
Brian M. Rivers · Morehouse School Of Medicine · R01 · FY2018 · MD

SOX9 Mediation of AR and ERG Driven Prostate Cancer

$361,050
Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2017 · CA

SOX9 Mediation of AR and ERG Driven Prostate Cancer

$361,050
Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2015 · CA

SOX9 Mediation of AR and ERG Driven Prostate Cancer

$361,050
Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2016 · CA

SOX9 Mediation of AR and ERG Driven Prostate Cancer

$361,050
Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA

SOX9 Mediation of AR and ERG Driven Prostate Cancer

$361,050
Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2014 · CA

Tumor Immunology & Host Response

$361,047
Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2014 · CA

The Role of Fgf Signaling in Vertebrate Development

$361,026
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Role of BMP and FGF signaling during limb development

$361,026
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Microarray Platform for Profiling Cancer Proteases

$361,018
Benjamin F Cravatt · Scripps Research Institute, The · R33 · FY2007 · CA

Race-related alternative splicing: novel targets in prostate cancer

$361,013
Steven R Patierno · Duke University · R01 · FY2017 · CA

Role of JMJD1A modifications in castration resistance of prostate cancer

$360,994
Jianfei Qi · University Of Maryland Baltimore · R01 · FY2023 · CA

Community Outreach and Engagement

$360,986
Folakemi T Odedina · Mayo Clinic Rochester · P30 · FY2025 · CA

MR Signal Amplification for Receptor Imaging

$360,985
Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2007 · EB

Coordinate Regulation of Oncogenic Signaling Pathways in SPOP Mutant Prostate Cancer

$360,976
Christopher E Barbieri · Weill Medical Coll Of Cornell Univ · R37 · FY2023 · CA

DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells

$360,922
Zihua Gong · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA

Survival and Recurrence of Dormant Cancer Cells

$360,922
Lewis A Chodosh · University Of Pennsylvania · R01 · FY2022 · CA

DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells

$360,922
Zihua Gong · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA

Aberrant tumor metabolism that enables AR antagonist-resistant prostate cancer

$360,922
Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA

Role of Perivascular Mesenchymal Stem Cells (pMSCs) in the Bone Marrow Niche and the Extracellular Matrix in the Control of Skeletal Metastasis

$360,922
Rodrigo Alfonso Somoza · Case Western Reserve University · R01 · FY2023 · CA

Epigenetic Reprogramming of AR Function in CRPC

$360,869
Myles A Brown · Beth Israel Deaconess Medical Center · P01 · FY2013 · CA

Cancer Control Research Training Curriculum

$360,858
Gary R Morrow · University Of Rochester · R25 · FY2012 · CA

Signaling mediators of CCL2/CCR2 and natural product discovery

$360,833
Piwen Wang · Charles R. Drew University Of Med & Sci · R35 · FY2023 · GM